LATEST

• REGULATORY Gaku Hashimoto to Return as Skipper of LDP Team on Drug Innovation
  March 17, 2026

• BUSINESS BMS Japan “On Track” to Double Sales by 2032 as Launch Wave Nears
  March 17, 2026

• REGULATORY Cabinet-Backed Health Insurance Bill Targets Childbirth Costs, Copay Reform
  March 16, 2026

• REGULATORY Japan Cabinet Approves Health Insurance Bill with OTC-Like Drug Charges
  March 16, 2026

• REGULATORY LDP Urges Action on Drug Supply Risks Linked to Reliance on Specific Countries
  March 16, 2026

• BUSINESS Hisamitsu Sets April 17 Shareholders Meeting to Approve Squeeze-Out
  March 16, 2026

• BUSINESS AbbVie Japan Files Rinvoq for Vitiligo
  March 16, 2026

• BUSINESS SSP Appoints Yoko Motoshima as New President
  March 16, 2026

• BUSINESS PMP Returns Slam Drug Makers' Leading Products, Prazaxa Cut 45%: Jiho Poll
  March 13, 2026

• BUSINESS Lilly to Invest Additional 20 Billion Yen in Japan's Seishin Plant
  March 13, 2026

• BUSINESS Fujifilm Invests in Austria’s Valanx Biotech to Boost ADC Technology
  March 13, 2026

• BUSINESS Merck, CDMO Cyto-Facto Join Hands on Cell and Gene Therapy
  March 13, 2026

• BUSINESS Anti-PD-1 Agonist Antibody Enters PI in Australia for Autoimmune Diseases: Meiji
  March 13, 2026

• REGULATORY 874 Defects or Health Damages Reported for Regenerative Medical Products in 1H FY2025
  March 13, 2026

• REGULATORY 10 Firms Win Approval for Bilanoa Generics, 2 Contenders for Fycompa
  February 17, 2026

• BUSINESS Trazenta Faces Multiple Patent Challenges Ahead of Anticipated Generic Entry
  February 4, 2026

• BUSINESS Recordati Snags Japan Rights to BMS’ Myelofibrosis Med Inrebic
  December 19, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19